Evidence map›Paper›PMID 40590805›Full record

ArticleInvestigative ophthalmology & visual science2025

Inhibitor of DNA-Binding 3 Is a Novel Regulator of Limbal Epithelial Cell Migration Via the EphA2/Akt Signaling Pathway.

Elwin D Clutter, Wending Yang, Jacob Han, Nihal Kaplan, Han Peng

Abstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elwin D ClutterDepartment of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States.
Wending YangDepartment of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States.
Jacob HanDepartment of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States.
Nihal KaplanDepartment of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States.
Han PengDepartment of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States.

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Devalingam Mahalingam · 1993 to 2026
$153.9M
Northwestern University Skin Disease Research Center Resource-based CenterP30AR075049 · NIAMS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Amy S Paller · 2019 to 2026
$6.6M
The Roles of Autophagy in Limbal/Corneal Epithelia.R01EY028560 · NEI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Han Peng · 2018 to 2026
$3.9M
Single-cell RNA sequencing reveals novel regulatory pathways in maintaining limbal epithelial stem cell homeostasisR01EY032922 · NEI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI PENG, HAN · 2021 to 2025
$2.0M
Ocular mustard keratopathy elicits induced autophagy, which is detrimental to the corneaR56EY036320 · NEI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI PENG, HAN · 2024 to 2024
$469k
Biostation CT (Cell Tracker)S10OD021704 · OD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI RAPPOPORT, JOSHUA ZACHARY · 2017 to 2017
$362k
The 10x Chromium System for High-Throughput Single Cell GenomicsS10OD025120 · OD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WANG, XINKUN · 2019 to 2019
$79k
NCI NIH HHS P30 CA060553NEI NIH HHS R01 EY028560NEI NIH HHS R01 EY032922NEI NIH HHS R56 EY036320NIAMS NIH HHS P30 AR075049NIH HHS S10 OD021704NIH HHS S10 OD025120
6 · The paper itself

Abstract

Purpose: Upon corneal injury, early and late transit amplifying (TA) cells, the progeny of epithelial stem cells, migrate to the site of the wound, which facilitates its closure. Understanding the targetable signals that guide such cell migration is essential for the development of novel wound-healing strategies. Methods: Single-cell RNA sequencing (scRNA-seq) was conducted in wild-type cornea. To investigate the role of inhibitor of DNA binding 3 (ID3) in the limbal epithelium, bulk RNA-seq was conducted in limbal epithelial cells with ID3 knockdown. hTCEpi cells were transfected with small interfering RNAs (siRNAs) against ID3, and cell migration was assessed using scratch wound assays. Results: The scRNA-seq revealed that ID3, a transcription factor, was preferentially expressed in the stem/early TA population of limbal epithelium. Bulk RNA-seq in limbal epithelial cells with ID3 knockdown suggested a role of ID3 in cell migration. Scratch wound assays confirmed that loss of ID3 in human limbal epithelial cells markedly accelerated wound sealing, indicating an inhibitory role of ID3 in cell migration. Gene Ontology analysis of the RNA-seq data suggested that ID3 negatively regulates EphA2 (a receptor tyrosine kinase) and Akt signaling, both of which have a critical role in cell migration. Consistently, loss of ID3 induced ligand-independent activation of EphA2, as well as enhanced phosphorylation of Akt proteins. Scratch wound assays demonstrated that both ligand-independent activation of EphA2 and phosphorylation of Akt were required for enhanced cell migration in cells lacking ID3. Conclusions: Our findings indicate that ID3, EphA2, and Akt form a novel signaling axis, which plays a critical role in corneal epithelial wound healing.

Indexed as

Cell MovementEpithelium, CornealInhibitor of Differentiation ProteinsLimbus CorneaeProto-Oncogene Proteins c-aktReceptor, EphA2AnimalsCells, CulturedCorneal InjuriesEpithelial CellsHumansMiceNeoplasm ProteinsRNA, Small InterferingSignal TransductionWound HealingEPHA2 protein, humanID3 protein, humanInhibitor of Differentiation ProteinsNeoplasm ProteinsProto-Oncogene Proteins c-aktReceptor, EphA2RNA, Small Interfering

Identifiers

PMID40590805
PMCPMC12227036

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.